HK1244506A1 - 用於流感病毒的減弱活疫苗 - Google Patents
用於流感病毒的減弱活疫苗Info
- Publication number
- HK1244506A1 HK1244506A1 HK18103889.8A HK18103889A HK1244506A1 HK 1244506 A1 HK1244506 A1 HK 1244506A1 HK 18103889 A HK18103889 A HK 18103889A HK 1244506 A1 HK1244506 A1 HK 1244506A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- influenza viruses
- live attenuated
- attenuated vaccines
- vaccines
- live
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462079227P | 2014-11-13 | 2014-11-13 | |
PCT/CN2015/094589 WO2016074644A1 (en) | 2014-11-13 | 2015-11-13 | Live attenuated vaccines for influenza viruses |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1244506A1 true HK1244506A1 (zh) | 2018-08-10 |
Family
ID=55953758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18103889.8A HK1244506A1 (zh) | 2014-11-13 | 2018-03-21 | 用於流感病毒的減弱活疫苗 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9827304B2 (zh) |
EP (1) | EP3218470B1 (zh) |
CN (1) | CN107208071B (zh) |
AU (1) | AU2015345579B2 (zh) |
HK (1) | HK1244506A1 (zh) |
WO (1) | WO2016074644A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2018449744A1 (en) * | 2018-11-16 | 2021-05-27 | Versitech Limited | Live attenuated influenza B virus compositions methods of making and using thereof |
CN109487008B (zh) * | 2018-12-26 | 2022-03-29 | 中元汇吉生物技术股份有限公司 | 呼吸道病原体的多重pcr检测试剂盒、用途及其使用方法 |
WO2020244605A1 (zh) * | 2019-06-04 | 2020-12-10 | 凌斌 | 重组非结构蛋白1、含此的重组流感病毒及免疫组成物及其用于制备流感病毒疫苗组成物的用途 |
EP4085131A4 (en) * | 2020-02-10 | 2024-03-13 | Versitech Ltd | AGAINST THE SARS-CORONAVIRUS 2 IMMUNOGENE COMPOSITIONS, METHOD FOR THEIR PRODUCTION AND THEIR USE |
US20230089695A1 (en) * | 2020-03-09 | 2023-03-23 | Versitech Limited | Compositions immunogenic against sars coronavirus 2, methods of making, and using thereof |
EP4263812A1 (en) * | 2020-12-17 | 2023-10-25 | Versitech Limited | Compositions immunogenic against influenza and sars coronavirus 2, methods of making and using thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166057A (en) * | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
WO2004094466A2 (en) * | 2003-04-23 | 2004-11-04 | Wisconsin Alumni Research Foundation | Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
EP2072058A1 (en) * | 2007-12-21 | 2009-06-24 | Avir Green Hills Biotechnology Research Development Trade Ag | Modified influenza virus |
IN2012DN00729A (zh) * | 2009-07-22 | 2015-06-19 | Avir Green Hills Biotechnology |
-
2015
- 2015-11-13 EP EP15858309.6A patent/EP3218470B1/en active Active
- 2015-11-13 WO PCT/CN2015/094589 patent/WO2016074644A1/en active Application Filing
- 2015-11-13 US US14/940,307 patent/US9827304B2/en active Active
- 2015-11-13 CN CN201580061643.XA patent/CN107208071B/zh active Active
- 2015-11-13 AU AU2015345579A patent/AU2015345579B2/en active Active
-
2018
- 2018-03-21 HK HK18103889.8A patent/HK1244506A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2016074644A1 (en) | 2016-05-19 |
EP3218470A1 (en) | 2017-09-20 |
CN107208071A (zh) | 2017-09-26 |
CN107208071B (zh) | 2021-11-30 |
US20160136261A1 (en) | 2016-05-19 |
EP3218470A4 (en) | 2018-04-11 |
AU2015345579A1 (en) | 2017-05-04 |
US9827304B2 (en) | 2017-11-28 |
AU2015345579B2 (en) | 2019-02-21 |
EP3218470B1 (en) | 2022-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT3393510T (lt) | Zikos viruso vakcina | |
SG10201913630YA (en) | Zika virus vaccine | |
SI3718565T1 (sl) | Cepiva za respiratorni virus | |
ZA201700952B (en) | Indoles for use in influenza virus infection | |
ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
GB201410971D0 (en) | Vaccine | |
PL3185899T3 (pl) | Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd | |
GB201406608D0 (en) | Virus | |
SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
HK1244506A1 (zh) | 用於流感病毒的減弱活疫苗 | |
GB201613191D0 (en) | Zika virus vaccine | |
IL248223B (en) | Compositions of vaccine | |
GB201419572D0 (en) | Virus | |
SG11201701279VA (en) | Alkylated influenza vaccines | |
IL249500A0 (en) | Reno vaccine system of influenza vaccine component | |
SI3188755T1 (sl) | Cepivo | |
ZA201608436B (en) | Live attenuated african horsesickness virus | |
GB201417214D0 (en) | Vaccine | |
PT3393510T (pt) | Vacina contra o vírus zika | |
IL249704A0 (en) | Influenza virus vaccines and their uses | |
IL249705A0 (en) | Influenza virus vaccines and their uses | |
GB201406470D0 (en) | Virus | |
GB201403582D0 (en) | Virus | |
GB201406628D0 (en) | Vaccine | |
GB201408046D0 (en) | Virus preparations |